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Abstract 
 
Post-translational modifications (PTMs) describe the chemical alteration of proteins after their 
biosynthesis in ribosomes. PTMs play important roles in cell biology including the regulation 
of gene expression, cell-cell interactions and the development of different diseases. A 
prominent class of PTMs is the side chain methylation of lysine. For the analysis and 
discrimination of differently methylated lysines antibodies are widely used, though, methylated 
peptide and protein targets are known to be particularly difficult to be differentiated by 
antibody-based affinity reagents; an additional challenge can be batch-to-batch reproducibility. 
The application of mass spectrometry techniques for methyllysine discrimination requires a 
complex sample preparation and is not suited for working in cells. The desire to overcome 
above-named challenges promoted the development of synthetic receptor molecules that 
recognize and bind methyllysines. Such ‘artificial antibodies’ are of interest for a number of 
applications, e.g. as reagents in biochemical assays, for the isolation and purification of post-
translationally methylated proteins and for the tracking of signalling pathways. Moreover, they 
offer new approaches in diagnostics and therapy. This review delivers an overview of the broad 
field of methyllysine binding and covers a wide range of synthetic receptors used for the 
recognition of methylated lysines including calixarenes, resorcinarenes, pillararenes, disulfide 
cyclophanes, cucurbituriles and acyclic receptors. 
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Very distinguished: The side chain methylation of lysine is a 
prominent post-translational modification. The desire to 
understand the function of this modification promoted the 
development of synthetic molecules that recognize and bind 
methylated lysines. This review delivers an overview of 
established methyllysine hosts and provides a summary of their 
affinities and applications.  
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1. Introduction 
 
Post-translational modifications (PTMs) describe the chemical alteration of proteins after their 
biosynthesis in ribosomes. They occur in almost all known proteins and only after post-
translational modification is the protein able to fulfil its biological duty in or out of the cell. 
One can differentiate four different types of PTMs: 1. addition of other proteins or peptides 
(e.g. ubiquitination), 2. change of the chemical nature of an amino acid (e.g. arginine  
citrulline), 3. structural alterations (e.g. formation of disulfide bridges) and 4. addition of other 
functionalities (e.g. methylation, phosphorylation, glycosylation). Together, PTMs play 
important roles in cell-biology including the regulation of gene expression, cell-cell 
interactions and development of diseases.[1]  
A well-studied class of proteins subjected to PTMs are histones. They are basic, i.e. cationic, 
proteins found in the eukaryotic cell nuclei and form complexes with the anionic DNA to form 
chromatin. To date five core histone proteins have been described, viz. H1, H2A, H2B, H3 and 
H4. Histones are rich in lysine and the accessibility of the DNA for transcription is regulated 
by PTMs in the lysine side-chains, generally by an interplay of acetylation and methylation.[2] 
Thereby, methylation and demethylation is catalyzed by respective enzymes. 
Methyltransferases introduce one, two or three methyl groups to the Nε positions of different 
lysine residues resulting in mono-, di- or trimethylation; demethylases promote the loss of 
methyl groups (Scheme 1).[3] Lysine methyltransferases and lysine demethylases as well as 
methyllysine binding proteins, e.g. chromodomain- and plant homeodomain-containing 
proteins, are essential drug targets.[4] One of the largest families of histone binding domains 
(histone readers) are plant homeodomain (PHD) fingers. They stabilize the chromatin by 
binding to post-translationally modified and unmodified H3 proteins. PHD fingers control the 
activity of nuclear enzymes maintaining the physiological PTM equilibrium and, therefore, are 
crucial for cell homeostasis.  
 
A) 
 
 
 
B) 
 
C) 
 
D) 
 
 
Scheme 1. A) Lysine (de-)methylation is catalyzed by methyltransferases and 
demethylases leading to B) monomethyl-, C) dimethyl- or D) trimethyllysine. Under 
physiological conditions all three species appear as ammonium ions. 
 
So far, the best characterized histone methylations are H3K4mex (histone H3 x times 
methylated at Lys in position 4), H3K9mex, H3K27mex and H4K20mex. Methylation at H3K4 
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is connected with active euchromatin, i.e. actively transcripted genes,[5] and methylation at 
H3K9 is typically found in gene silencing.[6] H3K27me3 is associated with inactive gene 
promoters,[7] whereas H4K20 methylation is a key player in genomic integrity.[8] Histone 
methylation patterns can predict the clinical outcome of a variety of cancers and especially the 
loss of H4K20 trimethylation is regarded as a hallmark of human cancer.[9] Lysine methylation 
is also playing a fundamental role in neuronal disorders such as depression. In the absence of 
stress the brain-derived neutrotropic factor (Bdnf) shows modest levels of histone H3 
acetylation and no H3K27 dimethylation. Chronic defeat stress – an animal model of human 
depression – induces demethylation of histone H3K27. Moreover, related patterns of histone 
acetylation and methylation play a crucial role in addiction.[10]    
 
The desire to analyze, understand and quantify lysine methylation promoted the development 
of synthetic molecules that recognize and bind methyllysines.[11] Antibodies against differently 
methylated lysines are widely used,[12] although methylated peptide and protein targets are 
known to be particularly difficult to differentiate by antibody-based affinity reagents.[13] 
Furthermore, most antibodies cannot penetrate cells[14] and they are expensive to produce 
requiring, in many cases, the use of animals. An additional challenge can be batch-to-batch 
reproducibility.[15] This leads to massive extra-costs for validating an antibody and to replace 
ineffective batches.[16] The application of other techniques for methyllysine discrimination 
such as mass spectrometry generated important tools for PTM analysis,[17] though, often require 
a complex sample preparation.[18] Mass spectroscopic analyses can be time-consuming and 
sometimes complicated due to complex mixtures containing low PTM concentrations and large 
ionized proteins.[19] Additionally, instrument-based techniques are not suited for working in 
cells.  
 
 
 
Scheme 2. Possible applications of synthetic receptors (‘artificial antibodies’) 
for post-translational modifications. 
 
Above drawbacks in analyzing and manipulating methyllysines and respective proteins led to 
the development of synthetic receptors (‘artificial antibodies’) for the discrimination and 
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detection of methyllysines in water and biological media as well as in cells.[20] They are well-
defined small molecules, stable under ambient conditions and can be produced – more or less 
cost-efficient – without the need for animals. Actual and potential applications of synthetic 
receptors for methyllysines are shown in Scheme 2.  
 
In the last years a broad range of synthetic ammonium ion receptors have been reported such 
as cyclic peptides, crown ethers, calixarenes and cyclodextrins.[21] Thereby, for the recognition 
of ammonium ions four types of interactions between host and guest are characteristic: 
 
1. Steric and molecular complementarity 
2. Ion pairs and salt bridges 
3. Hydrogen bonds 
4. Cation∙∙∙π interactions 
 
Organic solvents allow strong hydrogen bonding between host and guest resulting in higher 
associations constants than observed for polar solvents, such as methanol and water.[22] In these 
more challenging media, hydrogen bonds between host and guest will provide less impetus for 
binding.[23] As a consequence, other non-covalent interactions are amplified. In case of 
methyllysines their recognition is based on the complexation of methylammonium ions. 
Additional methyl groups at the NH2 moiety in ε-position of lysine does not change the overall 
charge, however, result in less hydrophilic side chains. Hence, C-H∙∙∙π interactions and the 
hydrophobic effect have a larger influence on the complexation.  
Obviously, the ideal synthetic receptor for methyllysines will be able to discriminate them from 
other amino acids and methylamines. However, it will also be able to distinguish between four 
lysines featuring the most subtle differences in size, shape, basicity and lipophilicity resulting 
from the presence of 0-3 methyl groups at the Nɛ position. Crystallographic studies of 
methylated lysines complexed by peptides and proteins revealed that di- and trimethylated 
lysine residues prefer so-called “aromatic cages”.[24, 25] The latter were the inspiration for quite 
a number of synthetic methyllysine receptors. However, some successful candidates not even 
contain phenyl moieties as discussed later.  
 
The dissociation constant (Kd) is a measure for the thermodynamic stability of a host/guest 
complex. It can be used to describe the affinity between receptor (host) and ligand (guest); a 
high affinity of both binding partners is expressed by a low dissociation constant of the 
complex. The most commonly used techniques for determining Kd values are: NMR 
spectroscopy and isothermal titration calorimetry (ITC),[26] fluorescence displacement (FD),[27] 
fluorescence anisotropy (FA),[28] and surface plasmon resonance SPR.[29] For comparison 
reasons this review uses only Kd values in µM. For some methyllysine receptors these were 
calculated from the respective association constant Ka (Kd=1/Ka). A detailed compilation of the 
dissociation constants for all compounds discussed here can be found in Tables 1-11 and the 
ESI (Tables S1-S8). As a matter of lucidity the lowest Kd values and highest selectivity are 
shaded in each table. 
Due their rather easy experimental set-up complexation studies in solution only deliver 
restricted information on the geometry of host/guest complexes. Complementary X-ray 
structures allow to study interactions between hosts and guests in more detail and give insight 
into respective conformational parameter such as distances and torsions angles. So far, five 
complexes of synthetic receptors with methylated lysines have been described in the 
Cambridge Structural Database (CSD) and the Protein Data Bank (PDB), respectively. They 
will be discussed in the corresponding sections of this review.  
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2. Calixarenes 
 
2.1. Sulfonatocalixarenes 
 
One way to mimic “aromatic cages” found in proteins are aromatic macrocycles with 
cyclophanes[30] as typical examples. Cyclophanes (=cyclic phenylalkanes) were one of the first 
synthetic receptors used for the recognition and complexation of alkylammonium ions. A 
prominent subfamily are so-called calix[n]arenes, i.e. m-cyclophanes featuring phenolic groups 
and a defined cavity; the digit in brackets defines the number of aromatic units.[31] The phenolic 
region of a calixarene is called lower rim, the opposite section upper rim. The best researched 
calixarenes are the cyclic tetramers, i.e. calix[4]arenes. They can exist in four different main 
conformations (cone, partial cone, 1,3-alternate and 1,2-alternate), which are determined by 
the respective lower rim substituents, temperature, solvent and possible complexing ions (e.g. 
Na+ will force a flexible calix[4]arene into the cone form).[32]  
Calixarenes and their derivatives are rather easy to synthesize and some show remarkable 
bioactivity.[33] This is also true for sulfonatocalixarenes,[34] which have already been studied 
extensively with respect to their inclusion properties in aqueous solution (ammonium ions,[35] 
amino acids,[36] biological buffer components,[37] neutral species[38]) as well as in solid state.[39] 
Studies carried out by Hof and co-workers[40] found that p-tetrasulfonatocalix[4]arene (1) 
(Scheme 3) is able to discriminate between tri-, di-, mono- and unmethylated lysine with 
dissociation constants of 27, 62, 250 and 1,923 μM, respectively, and a Kme0/Kme3 selectivity 
of 71 (NMR, sodium phosphate buffer) (Table 1). Using fluorescence displacement assays and 
glycine buffer even lower dissociation constants (7.7 μM for trimethyllysine) and higher 
selectivity (>130) have been observed.[41] Primary drivers for the recognition events are 
favorable enthalpies of binding (electrostatic interactions, non-classical hydrophobic 
effects).[42]  
 
 
 
Scheme 3. Structures of calixarenes 1-5 featuring varying 
lower and upper rim substituents as well as ring sizes.   
 
Further research revealed that biologically more relevant concentrations of sodium and 
potassium ions in the buffer medium decrease the affinity of methyllysines to 1 by a factor of 
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2-3; lowering the temperature decreases dissociations constants (ca. 2 μM/K) (Table S1).[43] 
Complexation studies with methylated and unmethylated peptides showed that both have 
higher affinities to 1, though lower selectivity, than observed for the simple amino acids. As 
one reason repulsive forces between the carboxylate anions of the amino acid guests and the 
sulfonato group of the host have been discussed. Another reason could be attractive secondary 
interactions between 1 and the amide backbone and neighboring side chains in the histone 
peptides.[44] By way of interest, 1 binds H3K4me3, H3K9me3 and H3K27me3 equally well (Kd 
=5.0-9.1 μM) as determined by ITC and, hence, possess a rather low specificity towards 
different trimethylated lysines sites.  
The interactions of tetrasulfonatocalix[4]arene (1) with trimethyllysines are in some cases 
strong enough to compete with those of natural protein receptors. It has been shown that 1 is 
able to interrupt the binding of histone H3K4me3 with its native protein binder ING2 PHD. By 
way of interest the calixarene host disrupts the interaction of ING2 PHD and the trimethylated 
histone (IC50 = 108 μM), though not between ING2 PHD and the dimethylated histone.[45]  
 
Table 1. Dissociation constants for the binding of 
p-tetrasulfonatocalix[4]arene (1) to differently 
methylated lysines and respective histone peptides 
(40 mM sodium phosphate buffer, pH 7.4). 
Ref. Guest 
Kd  
[μM] 
S[a] T [K] method 
[40] Kme0 1923 - 298 NMR 
[40] Kme1 250 8 298 NMR 
[40] Kme1 333 - 303 ITC 
[40] Kme2 62 31 298 NMR 
[40] Kme2 95 - 303 ITC 
[40] Kme3 27 71 298 NMR 
[40] Kme3 28 - 303 ITC 
[42] H3K4[b] 46  303 ITC 
[42] H3K4me3 5.0 9 303 ITC 
[42] H3K9 101  303 ITC 
[42] H3K9me3 7.2 14 303 ITC 
[42] H3K27 220  303 ITC 
[42] H3K27me3 5.4 41 303 ITC 
[42] H3K36 128  303 ITC 
[42] H3K36me3 9.1 14 303 ITC 
[a] S: Kme0/Kmex selectivity 
[b] H3K4 = +H3N-ARTKQTAY-CONH2; H3K9 = 
Ac-TARKSTGY-CONH2; H3K27 = Ac-
AARKSAPY-CONH2; H3K36 = Ac-
GGVKKPHY-CONH2 
 
The complexes of tetrasulfonatocalixarene (1) with dimethyllysine hen egg-white lysozyme[46] 
and cytochrome c containing nonmethylated lysines[47] give interesting insights into the driving 
forces for methyllysine recognition. In the asymmetric unit of the dimethyllysine hen egg-white 
lysozyme calixarene complex two host molecules bind to dimethyllysine residues and two bind 
to arginine residues. The calixarenes that complex the dimethyllysine are in a symmetrical cone 
conformation with interplanary angles of 61.7/62.7 ° and 65.1/66.6 °, respectively (Scheme 
4a). One of the Nɛ methyl groups of each guest points directly into the calixarene cavity. The 
distance between the carbon atom and the centroids of the calixarene phenyl rings range from 
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3.51 to 3.91 Å (four C-H∙∙∙π interactions). The second methyl group points towards two of the 
sulfonato residues [d(C∙∙∙O)=3.57, 3.46 Å] and develops only one C-H∙∙∙π interaction (3.89 Å) 
with the aromatic cavity. 
The asymmetric unit of the complex of 1 with cytochrome c contains three guest molecules, 
which all cap the protein at lysine residues. The calixarene host is again in a cone conformation, 
though its geometry is somewhat distorted (interplanary angles 51.4/86.7 °, 58.4/80.4 °, 
59.0/88.9 °). The lysine guests are interacting with the receptor cavity via their alkyl backbone. 
The found C-H∙∙∙π interactions involve carbon atoms Cɛ (2-3 contacts per host/guest unit, 3.27-
3.99 Å) and Cδ (1-2 contacts per host/guest unit, 3.73-3.97 Å) (Scheme 4b). The ε-ammonium 
unit is bend towards two the sulfonate groups preventing cation∙∙∙π interactions; a similar 
feature is observed in the complex of lysine with 1 (CSD code: WIXSOL)[48]. Taking under 
consideration the rather unspecific inclusion of lysine, dimethyllysine and arginine residues, 
the binding behaviour of 1 seems to be rather ‘promiscuous’ – at least in the solid state.  
 
A) 
 
B) 
 
 
Scheme 4. Details of the X-ray structures of tetrasulfonatocalixarene 1 with 
A) dimethyllysine hen egg-white lysozyme (PDB code: 4N0J/4PRU)[47] 
and B) cytochrome c (PDB codes: 3TYI;[46] unpublished alternative 
binding mode: 4YE1). (For both complexes only one host/guest unit is 
shown. Hydrogen atoms are omitted for clarity.) 
 
The conformation of the calixarene host is of crucial importance for its inclusion behaviour. 
The etherified calixarene 2 (Scheme 3) is in a so-called pinched cone conformation. Its closed 
cavity prevents efficient trimethyllysine uptake. For calixarenes 3 and 4 the ethylene glycol 
handles facilitate an open cavity leading to H3K27me3 affinities of 85 and 20 μM, 
respectively.[42] Also the ring size of the calixarene has been varied. The resulting 
hexasulfonatocalix[6]arene (5) still possesses a moderate selectivity for trimethylated lysine 
over lysine (Kme0/Kme3=5), though presents only low affinities towards both (5,000 μM for 
Kme0 and 1,074 μM for Kme3) (Table S2).[43]  
 
In order to further increase the affinity of p-tetrasulfonatocalixarene 1 towards higher 
methylated lysines, Hof and co-workers suggested to exchange one SO3
- group against a phenyl 
moiety or a bromine atom.[49] The resulting trisulfonato receptors (6-12) (Scheme 5) have the 
potential to develop additional C-H∙∙∙π interactions towards the backbone of the lysine guests. 
Within the series of receptors 6-12 only the calixarene featuring the underivatized phenyl 
substituent (6) showed higher affinity (16 μM) and selectivity (150) towards trimethylysine in 
comparison to 1 (27 μM, 71); no information has been given for the affinities towards the 
recognition mono- and dimethyllysines. In later studies hosts 6-8, 11 and 12 have been 
employed in fluorescence displacement assays to study their affinity to histone peptide H3K27 
in its trimethylated and unmethylated form.[50] As observed for mother compound 1, the 
affinities for the peptides are much higher than for the isolated amino acids (0.34-1.86 μM), 
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though the Kme0/Kmex selectivity decreases in most cases (e.g. from 150 to 25 for 6) (Table 
3).  
 
 
Scheme 5. For an improved binding of higher methylated 
lysines one SO3- group in 1 has been exchanged against a 
phenyl moiety or a bromine atom leading to trisulfonato 
calixarenes 6-12  
 
Table 3. Dissociation constants for the complexes of 
trisulfonatocalixarenes 6-12 with lysine and 
trimethyllysine and the respective histone peptide 
H3K27mex (pH 7.4). 
Host Guest 
Kd  
[μM] 
S[a] solv. method 
6[49] Kme0 2380 - A[b] NMR 
6[49] Kme3 16 150 A NMR 
6[49] Kme3 13 - A ITC 
6[50] H3K27 19 - B[c] FD 
6[50] H3K27me3 0.75 25 B FD 
7[49] Kme0 4762 - A NMR 
7[49] Kme3 476 10 A NMR 
7[50] H3K27 11.3 - B FD 
7[50] H3K27me3 0.88 13 B FD 
8[49] Kme0 7143 - A NMR 
8[49] Kme3 169 42 A NMR 
8[50] H3K27 23 - B FD 
8[50] H3K27me3 1.86 12 B FD 
9[49] Kme0 9091 - A NMR 
9[49] Kme3 588 16 A NMR 
10[49] Kme0 5000 - A NMR 
10[49] Kme3 192 26 A NMR 
11[50] H3K27 2.7 - B FD 
11[50] H3K27me3 0.34 8 B FD 
12[49] Kme0 2273 - A NMR 
12[49] Kme3 256 9 A NMR 
12[50] H3K27 11.3 - B FD 
12[50] H3K27me3 0.88 13 B FD 
[a] S: Kme0/Kmex selectivity 
[b] A: 40 mM sodium phosphate buffer 
[c] B: 10 mM sodium phosphate buffer 
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Only recently, the interactions of calixarenes 6 and 12 with cytochrome c have been studied in 
solution and the crystalline state (PDB codes: 5KPF for 6 and 5LFT for 12).51 Though only 
unmethylated lysines are available in cytochrome c, the dissociation constant for the complex 
with 12 is 20 µM. This is slightly lower than for the complex of cytochrome c with parent 
calixarene 1 (Kd=28 µM). In the crystalline complexes of 6 and 12 the NH3
+ moieties of the 
lysine residues avoid the cavity of the calixarenes similar to the respective X-ray structure of 
1.  
 
Kimura et al. employed trisulfonated calixarenes for the design of multivalent ligands.[52] The 
conjugation of 6 via short amide linkers delivered mono-, di- and trivalent (13) receptors 
(Scheme 6). The di- and trivalent ligands have higher binding affinities for methylated and 
nonmethylated histones (0.39-0.86 μM) than the monovalent receptor (8.9-20.4 μM) (Table 4). 
Noteworthy, for the trivalent system the Kd differences of respective complexes with histones 
H3 and H4, acetylated histone H4KAc and H3K27me3 are only rather small. H3 and H4 are 
rich in arginine and lysine, which suggests that nonspecific electrostatic interactions between 
the charged guest and the calixarene host overrule the more discriminating cation∙∙∙π and C-
H∙∙∙π interactions between the methylated lysines the host cavity.[53] It should also be 
considered that in this case the peptides were immobilized on a chip and the binding has been 
studied using surface plasmon resonance (SPR).  
 
 
 
Scheme 6. For trivalent receptor 13 three molecules of calixarene 6 
have been conjugated via amide linkers. The affinity of 13 to 
trimethyllysine is almost 23 times higher than observed for the 
respective monovalent host. 
 
Further research focussed on discriminating lysine trimethylation at specific lysine residues, 
viz. H3K9me3 and H3K4me3. For that purpose a series of calixarene amides and sulfonamides 
(14-19) has been synthesized (Scheme 7).[44],[45] They feature a somewhat higher flexibility in 
comparison to the biphenyl calixarenes discussed above. Most (sulfon)amide receptors bind to 
H3K9me3 and H3K4me3 with dissociation constants below 1 μM as determined by 
fluorescence displacement assays (1: Kd=0.12 μM [H3K9me3], 0.02 μM [H3K4me3]; 14, 16-
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18: Kd=0.14-0.49 μM [H3K9me3], 0.02-0.09 μM [H3K4me3]). Only for hosts 15 and 19 lower 
affinities have been found (15: Kd=4.8 μM [H3K9me3], 7.8 μM [H3K4me3]; 19: Kd=0.51 μM 
[H3K9me3], 1.6 μM [H3K4me3]). The H3K9me3/H3K4me3 selectivity is rather low for 15, 18 
and 19 (0.3-1.6) and somewhat higher for 14 (9.5) and 17 (9.8), which is similar to the one of 
calixarene 1 (7.8) (Table S3). (N.B.: Due to the different analytical methods applied a direct 
comparison with data from Tables 1 and 2 is difficult.) 
 
Table 4. Dissociation constants Kd [μM] for receptor 6 as 
mono-, di - and trivalent amide conjugate to H4 and H3 
tails (SPR, chip-immobilized peptides). 
 Peptide 
Host H4[a] H4KAc[b] H3[c] H3K27me3[d] 
Monovalent 17.8 10.0 20.4 8.9 
Divalent 1.8 3.3 1.8 0.39 
Trivalent (13) 0.73 0.86 0.51 0.39 
[a] H-SGRGKGGKGLGKGGAKRHRKGGK(biotin)-NH2 
[b] H-SGRG-K(Ac)-GG-K(Ac)-GLG-K(Ac)-GGA-K(Ac)-
RHR-K(Ac)-GGK(biotin)-NH2 
[c] Ac-RKSTGGKAPRKQLATKAAR-Kme0-GGK(biotin)-NH2 
[d] Ac-RKSTGGKAPRKQLATKAAR-Kme3-GGK(biotin)-NH2 
 
 
Scheme 7. Structures of sulfonatocalixarenes 14-20 featuring one or two aromatic substituents at the upper 
rim.   
 
By way of interest, calixarenes 1 and 14-16 are able to disrupt the binding between the natural 
histone binder CHD4 PHD2[54] and histone H3K9me3 (Kd=0.9 μM) in vitro without disturbing 
the interaction between CHD4 and the unmethylated histone H3K9me0 (Kd=19 μM); 
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compound 14 showed the highest activity. Furthermore, all four compounds are active in 
disrupting heterochromatin markers in cells.[45]  
Due to its high affinities for trimethylated peptides, calixarene 14 has been employed in 
supramolecular affinity chromatography for methylation-targeted proteomics. Linking 14 to 
agarose beads allowed the resolution of histone peptides (H3K4mex, H3K27mex and 
H3K27mex) on the basis of their methylation.
[55, 56]  
 
The recognition and purification of methyllysines with calixarenes is a crucial achievement, 
though also their quantification has been in the focus. In 2013, a macrocyclic sensor array and 
its method of use have been patented.[57] Thereby, a macrocycle is connected to a dye for 
identifying histone-code-related analytes. Several macrocycles (e.g. calix[n]arenes, cyclo-
dextrines, cucurbit[n]urils), analytes (e.g. methyllysines, methylarginines, phosphotyrosines) 
and fluorophores (e.g. fluorescein, dansyl, pyrene) have been disclosed. Only recently, Beatty 
et al. presented trisulfonatocalixarene 20 (Scheme 7) as a tool for photochemical sensing of 
trimethyllysines in biological media.[58] Macrocycle 20 features intrinsic fluorescence[59] and 
the recognition and sensing processes tolerate various salts, metal ions and enzymatic 
cofactors.  
 
A) 
 
 
B) 
 
 
Scheme 8. A) Structure of NBD-labelled host 21. B) After the selective 
binding of 21 to a trimethylated site of the peptide, a free lysine residue 
nearby reacts with the NBD moiety in an SNAr reaction. 
 
Gober and Waters used trisulfonatocalixarene 21 for the affinity labelling of Kme3-containing 
histone peptides (Scheme 8). Thereby, the receptor unit of the molecule complexes 
trimethyllysine in the peptide guest and the nitrobenzoxadiazole (NBD) group acts as the 
reagent covalently labelling a nonmethylated lysine in the same peptide (SNAr mechanism). 
The selectivity and rate of the labelling reaction proved to be significantly dependent on salt 
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and reagent concentration as well as pH. The utility of this new tool has been demonstrated in 
a turn-on fluorescence HDAC assay.[60] NBD is a particularly attractive fluorophore as its 
photophysical properties allow the use of a fluorescein isothiocyanate (FITC) filter.[61] 
 
 
2.2. Carboxycalixarenes 
 
Leung, Gruber and co-workers described a simple, readily synthesized monocarboxycalixarene 
(22) that selectively binds to di/trimethylammonium groups (Table 6).[62] In comparison to 
respective tri- and tetrasulfonatocalixarenes a monocarboxycalixarene is bearing only a single 
charge with possible advantages with respect to cell permeability. Furthermore, the complex 
of a monocarboxycalixarene and lysines will be neutral, which could be of interest for the 
extraction or the delivery of (methylated) lysines. Carboxycalixarene 22 binds di- and 
trimethyllysine with dissociations constants of 70 μM and 60 μM, respectively, though the 
affinities towards non- and monomethylated lysines are very low (Kd>500 μM) (Table 5). 
Receptor 22 is able to recognize methyllysines even in complex mixtures such as E. coli cell 
lysate as demonstrated by NMR spectroscopy.  
 
Table 5. Dissociation constants of 
carboxycalixarene 22 with differently 
methylated lysine guests (300 K, 
NMR, 50 mM sodium phosphate 
buffer, pH 7.5). 
 
 
 
 
Guest Kd [μM] 
Kme0 >500 
Kme1 >500 
Kme2 70 
Kme3 60 
PATGGV-Kme1-KPHRY >500 
PATGGV-Kme2-KPHRY 60 
PATGGV-Kme3-KPHRY 65 
AR-Kme1-STGGK >500 
AR-Kme2-STGGK 50 
AR-Kme3-STGGK 50 
choline 65 
carnitine 60 
meldonium 50 
4-dimethylaminopyridine 
(DMAP) 
95 
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The energy-minimized complexes of 22 with methyllysines reveal, that only for higher 
methylated lysines cation···π-interactions contribute to the recognition event (Scheme 9). 
Furthermore, C-H···π-interactions seem to play a vital role for the formation and the stability 
of the host/guest complexes. Di- und trimethyllysine develop four and five of these contacts, 
respectively. Thereby, all of the N-methyl groups are involved in the interaction. In the case of 
monomethyllysine two N-H∙∙∙O-hydrogen bond prevents the occurrence of C-H···π- and 
cation···π-contacts.  
In the energy-minimized structure of 22 with lysine three C-H···π-interactions and an 
intramolecular N-H∙∙∙O-hydrogen bond involving the guest carboxylate and the ε-ammonium 
unit has been observed. The N-H∙∙∙O prevent a close contact of the ammonium cation with the 
π-electron rich cavity. Such a behavior has already been found in the X-ray structure of lysine 
in the complex with tetrasulfonatocalixarene (1),[48] cytochrome c[47] and 
hexaphosphonatocalix[6]arene (PDB code: 5LYC),[63] respectively. 
 
A) 
 
 
B) 
 
 
C) 
 
D) 
 
 
Scheme 9. The energy-minimized host/guest complexes of 22 with trimethyllysine (A), 
dimethyllysine (B), monomethyllysine (C) and lysine (D) demonstrate the preference 
for higher methylated lysines. Only in A) and B) stabilizing C-H∙∙∙π and cation∙∙∙π 
interactions are observed. (MacroModel V.9.8; OPLS_2001 force field; MCMM; 
solvent: water; 20,000 steps.) 
 
In contrast to tetra- and trisulfonatocalixarenes the binding of 22 to the di- and trimethyllysine 
motif does not improve significantly when changing from free amino acids to peptides (Kd=50-
65 μM) (Table 5). The peptide PATGGV-Kme3-KPHRY is actually bound even worse than 
the free amino acid – despite the fact that the trimethyllysine has a direct lysine neighbor in the 
peptide. Host 22 only contains one anionic charge at the upper rim, though recognizes di- and 
trimethyllysines in the same order of magnitude as tetrasulfonatocalixarene 1. Hence, the 
repulsive forces between host and the amino acid carboxylate are much lower in 22 compared 
to 1. As a consequence, the more or less unchanged affinities between 22 and the methyllysine 
peptides must be primarily attributed to the lack secondary interactions between host and guest.  
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2.3. Structure-activity relationship of calixarenes 
 
Due to the diverse analytical methods employed for the determination of the dissociation 
constants, structure-activity relationships of the different calixarene hosts needs to be discussed 
cautiously. Here, additional work seems necessary in order to gain more reliable data. In 
general, it can be stated that higher charged receptors lead to higher affinities and selectivity (1 
vs. 22). Calix[4]arenes are favoured over calix[6]arenes (1 vs. 5) and alternative anionic groups 
at the upper rim lead to similar affinities for trimethyllysines. 
In tetrasulfonatocalixarenes, the substitution of one SO3
- group against a non-functionalized 
phenyl substituent improves the binding of trimethyllysine and the Kme0/Kmex selectivity (1 
vs. 6). However, functionalized phenyl substituents as in 7-11 result in drastically decreased 
binding affinities and selectivity. In contrast, for histone peptide H3K27me3 the electronically-
activated p-methylphenyl group at the upper rim (11) delivered the highest affinity. The phenyl 
moiety can also be attached to the calixarene via amide and sulphonamide bonds (14-19). The 
additional flexibility resulted in highly active receptors for histone peptides H3K4me3 and 
H3K9me3. It is somewhat surprising that also the plain tetrasulfonatocalixarene 1 is able to 
complex both peptides with nanomolar affinity.  
 
 
3. Resorcinarenes  
 
Similar to calixarenes, resorcinarenes are m-cyclophanes, though bear two phenol groups at 
each aromatic moiety instead of one. Resulting from their synthesis most resorcinarenes feature 
additional alkyl groups at the methylene bridges. Their cavity size is comparable to those of 
calixarenes. Four of the eight phenolic protons of resorcinarenes can be dissociated at pH >12. 
The introduction of electron-withdrawing groups (such as –CN) increases the OH acidity of 
the resorcinarene resulting in a pKa in the physiological pH region.[64] Chen and co-workers 
deployed this phenomenon in tetracyano receptor 23 (Scheme 10), which proved to be a 
powerful receptor for tetraalkylammonium ions with dissociation constants of 0.9-1.7 μM.[65] 
Hamilton and co-workers further studied this receptor as methyllysine host revealing a 
dissociations constant of 21 μM for Kme3, 68 μM for Kme2, 476 μM for Kme1 and over 1,000 
μM for nonmethylated lysine.[66] These are comparable to the values found for 
tetrasulfonatocalixarene (1). Both receptors, 1 and 23, have been successfully screened for their 
potential to inhibit the KDM4A(=JMJD2A)-catalysed demethylation of a histone peptide 
(H3K9me3) in vitro.  
 
 
 
Scheme 10. Structure of tetracyanoresorcinarene 23. 
The electron-withdrawing cyano groups result in a 
lower pKa compared to the mother resorcinarene and, 
hence, improve receptor solubility and the binding of 
alkylammonium ions.   
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Despite their strong O-H∙∙∙O hydrogen bonds between adjacent OH functions resorcinarenes 
are quite flexible molecules; bridging the phenol moieties leads to more rigid cavitands. An 
example are tetraphosphonate hosts in which two OH groups of neighboring arene units are 
each connected via a P=O bridge. This family of cavitands proved successful as synthetic 
receptors for N-methylammonium salts as reported for receptor 24.[67] (Scheme 11) 
Interestingly, the authors could also show that for tetraphosphonate cavitands the depth of 
insertion of an N-Me group into a host cavity – determined by X-ray crystallography – can be 
correlated to the binding constant. The affinity for the N+-Me group originates from three types 
of non-covalent interactions between host and guest: a) cation∙∙∙dipole interactions (N+···O═P), 
b) cation∙∙∙π interactions of the methyl group with the aromatic cavity and c) two hydrogen 
bonds between the two nitrogen protons and two adjacent P═O bridges. By way of interest, 
these features are also found in the X-ray structures of respective tetraphosphonates with 
monomethyllysines as reported by Geremia, Dalcanale and co-workers,[68] viz. 25 in its 
complex with methyllysine ∙ 2 HCl ∙ 6.4 CF3CH2OH ∙ H2O (CSD code: OJISEH) and 26 in its 
complex with methyllysine ∙ HCl ∙ H2O (CSD code: IKOZUF) (Scheme 12).  
 
 
 
Scheme 11. Tetraphosphonate cavitands 24-27 
feature different alkyl residues at the methylene 
bridge (R1) and the phosphonate ester (R2).  
 
 
 
Scheme 12. X-ray structure of 25 in its complex 
with methyllysine ∙ 2 HCl, CF3CH2OH and water 
(1:6.4:1), CSD code: OJISEH. (Only the cavitand 
and the methyllysine guest are shown.) 
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For cavitands 26 and 27 the dissociations constants of their complexes with monomethyllysine 
have been determined. Unsurprisingly, the complex in MeOH (27: Kd=0.9 μM) has a higher 
stability than those in aqueous media (26: Kd=671 μM in H2O; 885 μM in NaCl-containing 
sodium phosphate buffer) (Table S5). Data for the complexation of non-methylated or di- and 
trimethylated is not given in the reference.  
In the following tetraphosphonate cavitands have been applied for the development of an 
analytical platform based on plasmon-free surface enhanced Raman scattering (SERS). Using 
this approach Alessandri et al. have been able to distinguish N-methyllysine hydrochloride 
from lysine hydrochloride in water.[69] Later a tetraphosphonate cavitand for the recognition of 
monomethyllysine in histone peptides has been introduced. It allows the discrimination of 
single monomethylated peptides from multi monomethylated ones.[70]  
 
Hooley, Zhong and co-workers introduced a fluorescence-based supramolecular tandem assay 
for the in situ monitoring of a lysine demethylase (JMJD2E) or methyltransferase (PRDM9).[71] 
This site-selective displacement assay system contains only three resorcinarene-based 
cavitands (28-30) (Scheme 13). As all three have different charges their combination allows 
the simultaneous investigation of different methylation sites, e.g. peptide sequence AR-Kme3-
ST (H3K9me3) over T-Kme3-QTA (H3K4me3) and AAR-Kme3-S (H3K27me3). (N.B.: 
Receptor 30 featuring four positive charges is able to recognize an alkylammonium ion!) 
 
 
 
Scheme 13. Structures of cavitands 28-30. 
Receptor 28 and related hosts[72] are well known 
for their high affinities towards alkylammonium 
ions.[73] 
 
 
4. Pillararenes 
 
Not all electron-rich macrocycles have high affinities to alkylammonium ions and are suited to 
discriminate methyllysines as demonstrated by pillararene 31 (Scheme 14).[74] It features ten 
carboxyl groups as well as a stable cavity and is able to bind basic amino acids such as Lys, 
Arg and His with dissociation constants of 555 μM, 169 μM and 667 μM. Driving forces are 
electrostatic interactions between COO- and the cationic side chains and hydrophobic 
interactions. The complex of 31 with trimethyllysine was found to be less stable as KMe3 is 
not able to act as a hydrogen bond donor in contrast to Lys.  
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Scheme 14. Pillararene 31 has a stable, electron-rich 
cavity though binds lysine (555 μM) with a higher 
affinity than trimethyllysine (769 μM).  
 
 
5. Disulfide cyclophanes 
 
Already back in 1990 Dougherty et al. developed a cyclophane consisting of two xylene and 
two ethenoanthracene units connected via ether bridges. It binds acetylcholine with a 
dissociation constant of 50 μM, a value comparable to those of biological recognition sites.[75] 
In the following the xylene units have been replaced by a series of (hetero)aromatic units 
(Scheme 15a).[76] The resulting receptors favor peralkylated ammonium ions over lower 
alkylated ammonium ions due to the higher desolvation barriers for the latter. Later, the group 
demonstrated the importance of cation∙∙∙π interactions for the complexation of alkylammonium 
ions.[77] In 2008, Otto and co-workers[78] employed the – appropriately functionalized – 
building blocks of the first Dougherty receptor for the composition of a dynamic combinatorial 
library (DCL).[79] The components of this library proved to be disulfide macrocycles with 32 
as one example (Scheme 15b). All its members have been studied towards its ability to 
recognize peralkylated ammonium ions, which were also used as templates in the reaction.  
 
A) 
 
B) 
 
 
Scheme 15. A) General structure of Dougherty’s ethenoanthracene receptors. B) Structure of disulfide 
cyclophane 32 found in a dynamic combinatorial library (DCL) with A and B as only building blocks.  
 
Waters and co-workers used A, B and related aromatic dithiols to create a dynamic 
combinatorial library similar to the one of Otto, though, in this case dipeptide Ac-Kme3-G-NH2 
21 
 
has been used as molecular target. By way of interest, again receptor 32 (Scheme 15c) was the 
most amplified and was found – after separation and purification – to bind methylated lysines. 
The binding affinity for histone H3K9me3 is about 25 μM, which is similar to the binding of 
native HP1 chromodomain, a biological methyllysine receptor (Table 9).[80] Moreover, 32 can 
discriminate differently methylated lysines.[81] Interestingly, the binding strength and 
selectivity varies quite drastically depending on the method used for its determination, e.g. 25 
μM vs. 2.6 μM  and >48 vs. 8.5 for histone H3K9me3 (fluorescence anisotropy vs. ITC).[82] The 
authors explain this with incomplete desalting of the samples measured by fluorescence 
anisotropy.  
 
Table 9. Dissociation constants for the binding of disulfide 
macrocycle 32 and HP1 chromodomain to histone peptide 
H3K9 in its different methylation states 
Host Guest Kd [μM] S[a] solv. method 
rac-32[81] H3K9me0 >1200 - A[b] FA 
rac-32[81] H3K9me1 166 >7 A FA 
rac-32[81] H3K9me2 58 >20 A FA 
rac-32[81] H3K9me3 25 >48 A FA 
rac-32[82] H3K9me0 22 - B[c] ITC 
rac-32[82
]
 H3K9me1 13.9 1.6 B ITC 
rac-32[82] H3K9me2 6.3 3.5 B ITC 
rac-32[82] H3K9me3 2.6 8.5 B ITC 
HP1[80] H3K9me0 >1000 - C[d] FA 
HP1[80] H3K9me1 96 >10 C FA 
HP1[80] H3K9me2 15 >66 C FA 
HP1[80] H3K9me3 10 >100 C FA 
[a] S: Kme0/Kmex selectivity 
[b] A: 10 mM phosphate buffer; 300 K; pH 8.5 
[c] B: 10 mM borate buffer; 299 K; pH 8.5 
[d] C: phosphate buffer, 25 mM NaCl, 1 mM DTT; 288 K; 
pH 7.5 
 
In order to increase and vary the binding affinities and selectivity of receptor 32, the Waters 
group used the DCL approach to generate macrocycles 33-38 (Scheme 16). They have 
impressively high affinities to histone peptide H3K9 in its different methylation forms ranging 
from 0.13-2.6 μM (trimethylation), 0.18-13.2 μM (dimethylation), 1.0-40 μM (mono-
methylation) and 1.8-58 μM (unmethylated peptide) (Table S6). [82],[83],[84] For a broad 
application of disulfide receptors as trimethyllysine sensors a late stage modification has been 
suggested.[85] As other synthetic receptors present here the hosts from dynamic combinatorial 
libraries have been employed in fluorogenic sensor platforms using an indicator displacement 
system.[86] 
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Scheme 16. The variation of the aryl unit in the Waters receptor (32) produce disulfide 
macrocycles 33-38. Two COOH functions at the exchangeable aromatic moiety as in 33, 35 and 
37 result in lower dissociation constants (0.13-0.30 μM) and – in most cases – better selectivity 
(8.1-35) compared to 32 (Kd=2.6 μM; 8.5). 
 
Disulfide cyclophanes 32-38 show interesting structure-activity relationships primarily based 
on the location and number of COO- functions at the individual aryl units. When the position 
of the carboxylate in 32 is changed from meta to ortho (34) or a phenylene residue is inserted 
(38) the affinity towards methyllysines is scarcely affected (change from 2.6 to 2.3 and 2.6/2.2, 
respectively). In case of 34 the Kme0/Kme3 selectivity stays more or less the same (change 
from 8.5 to 9.6), for 38 it decreases significantly (2.7/4.7). The exchange of the benzene moiety 
in 32 against a naphthalene ring – leading to host 36 – results in a much higher Kme0/Kme3 
selectivity (>58) than observed for 32 (8.5), though a more or less unchanged affinity for 
trimethyllysine (1.4 μM). An explanation deliver improved C-H∙∙∙π-interactions facilitated by 
the naphthalene ring, which benefit the higher methylated lysines. Cyclophanes 33, 35 and 37 
are featuring an additional COO- group each, which support secondary interactions with the 
peptide chain. These obviously lead to much lower dissociation constants for the complex with 
trimethyllysine (0.13-0.30 μM) and very good (33, 35) or good (37) Kme0/Kme3 selectivity 
(35, 34 and 16/8.1, respectively).  
Most receptors discussed here have been designed to achieve high affinities and selectivity 
towards trimethylation. Though, one isomer of macrocycle 37 shows a slightly higher affinity 
for dimethylated histone protein H3K9 (Kd=0.20 μM) than for the trimethylated one (Kd=0.22 
μM). This has also been demonstrated for peptide Ac-Kmex GGY-NH2 with Kd=3.32 μM 
(dimethylation) and 4.30 μM (trimethylation), respectively.[84]  
 
Macrocycle 33 is a good example for a synthetic receptor with comparably high affinities for 
trimethyllysines in different peptides, though different Kme0/Kmex selectivity. For histone 
peptides H3K9 (Ac-WGGG-QTAR-Kmex-STG-NH2) and H3K36 (Ac-WGGG-TGGV-Kmex-
KPH-NH2) the trimethylated lysine is complexed with the same affinity (Kd=0.3 μM). 
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However, the affinities of 33 for the unmethylated histone peptides are 10.5 μM (H3K9) and 
≈70 μM (H3K36).[82]  
For receptor 33 the Waters group also studied the binding affinity towards lysine and 
trimethyllysines under the influence of neighboring arginine and lysine residues, i.e. possible 
secondary interactions between host and guest. Their research revealed that, in general, the 
binding improves when additional cationic side chains (Arg or Lys) are present in the peptide. 
However, the position of the additional cationic amino acid residue has only a little influence 
on the binding affinities (Kd=0.31-0.62 μM) and the Kme0/Kme3 selectivity decreases in most 
cases (20-58), except for a lysine in direct neighborhood (100) (Table 10).[87]  
 
Table 10. Dissociation constants for the binding 
of 33 to non- and trimethylated model peptides 
featuring varying distances of a neighboring Arg 
and Lys. (299 K, ITC, 10 mM borate buffer, pH 
8.5)[87]   
Ac-WGGGG-Zi-3-Zi-2-Zi-1-Kmex-GGG-NH2 
Zi-3 Zi-2 Zi-1 x 
Kd  
[μM] 
Kme0/Kme3 
selectivity 
G G G 0 140 
67 
G G G 3 2.1 
G G R 0 12 
20 
G G R 3 0.62 
G R G 0 13 
29 
G R G 3 0.46 
R G G 0 17 
34 
R G G 3 0.50 
G G K 0 31 
100 
G G K 3 0.31 
G K G 0 23 
58 
G K G 3 0.40 
 
6. Cucurbiturils 
 
Cucurbit[n]urils are synthetic macrocycles consisting of glycoluril monomers linked by 
methylene bridges. In contrast to all other synthetic hosts discussed here, cucurbiturils do not 
contain aromatic moieties. Nevertheless, they have proven as versatile receptors in 
supramolecular chemistry.[88] Unlike underivatized calixarenes and other cyclophanes 
cucurbiturils are water-soluble. In the last years mainly cucurbit[7]uril (Scheme 17) has been 
studied with respect to its ability to form complexes with lysine and other amino acids[89] as 
well as tetraalkylammonium ions (Kd=1.0-8.3 μM).[90],[91] In 2013, Macartney and co-worker 
studied the selective molecular recognition of methylated lysines by cucurbiturils with 
dissociations constants of 0.5 μM, 17 μM, 556 μM, 1,887 μM for tri-, di- and monomethylation 
as well as lysine, respectively.[92] Interestingly, 39 binds to trimethylated lysine over 3,500 
times better than to lysine. This is the highest selectivity observed so far for the recognition of 
methylated lysines. Thus, cucurbit[7]uril has even a higher selectivity than natural protein 
receptors (ING2 = 1,500[93], ADDATRX = 7.4[94] / 28[95], HP1 > 100[80]) (Table S7). In 
cucurbituril complexes the high affinities can clearly not be explained by cation∙∙∙π and C-H∙∙∙π 
interactions, though by the release of high energy water from the hydrophobic cavity (non-
classical hydrophobic effect)[96] and ion-dipole interactions. 
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Scheme 17. Cucurbit[7]uril (39) is the 
synthetic receptor with the highest 
selectivity for trimethylated lysine 
observed so far.  
 
Recently, Crowley and co-workers described the complex of dimethylated Ralstonia 
solanacearum lectin with cucurbit[7]uril (39) (PDB codes: 6F7W/6F7X).[97] In the X-ray 
structure they found three different modes of binding, suggesting an incomplete filled host 
cavity (Scheme 18), which could also explain the rather low affinity in solution (Kd≈1,000 μM). 
Like calixarene 1, cucurbit[7]uril (39) has also been reported to recognize proteins not 
containing methyllysines with rather high affinity. An example is the complex with human 
insulin (PDB code: 3Q6E), in which the N-terminal phenylalanine residue is preferentially 
recognized by the cucurbituril over other amino acid sidechains (Kd=0.7 μM).[98] 
 
 
 
Scheme 18. Detail of the complex of cucurbit[7]uril 
(39) and dimethylated Ralstonia solanacearum 
lectin (PDB code: 6F7W).[97] (Only one host/guest 
entity is shown. Hydrogen atoms are omitted for 
clarity.) 
 
Zong and co-workers employed sulfonatocalixarenes 1 and 5 as well as cucurbituril 39 in the 
separation of methylated histone proteins by host-mediated capillary electrophoresis.[99] The 
molecular recognition event changes the electrophoretic mobility of the differently methylated 
peptides. The addition of calixarenes 1 and 5 to the background electrolyte led to their 
successful separation; cucurbituril 39 has been less effective.   
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7. Acyclic receptors  
 
The recognition of amino acids by synthetic receptors is not restricted to cyclic host systems. 
Early examples for acyclic receptors comprise guanidium receptors[100] introduced by Schmuck 
and the molecular tweezers[101] of Klärner and Schrader. Other examples of acyclic hosts are 
tripodal receptors on the base of substituted trimethyl- and triethylbenzenes. These have proven 
as very successful hosts especially for the recognition of sugars.[102] So far only one tripodal 
receptor, viz. trisindol 40 (Scheme 19), has been studied towards its capacity to complex 
methylated lysines. However, as 40 shows a low degree of preorganization only unsatisfying 
affinities towards trimethyllysine have been observed (15,873 μM[103]/4,000 μM[104]). Due to 
their higher hydrophobicity tetraalkylammonium ions with long alkyl chains are complexed 
with much higher affinities, e.g. tetrabutylammonium chloride with a dissociations constant of 
37 μM[103]/142 μM (Table S8).[104] 
 
 
Scheme 19. Trisindol receptor 40 
complexes long chain tetraalkyl-
ammonium ions with high affinitiy, 
though, is less suited for the binding of 
trimethyllysine. 
 
 
8. Summary and outlook 
 
The article on methyllysine recognition by tetrasulfonatocalixarene 1 by Hof and his group in 
2010 demonstrated for the first time the feasibility of small molecule receptors as potential 
hosts for post-translationally modified lysines as free amino acids, in peptides and in proteins. 
Since then quite a number of receptors for differently methylated lysines has been described. 
Some of them were already studied before with respect to their ability to bind alkylammonium 
ions, some were newly introduced. Interestingly, only one family of methyllysine hosts, viz. 
the ethenoanthraceno receptors, is chiral despite the methyllysine guests occur only as single 
enantiomer – at least in natural peptides and proteins.  
 
In general, it can be stated that methyllysine hosts have higher affinities to methyllysine-
containing peptides and proteins than to methyllysines as amino acids. An explanation deliver 
attractive secondary interactions between the synthetic hosts and the peptide guests. However, 
in some cases it is problematic to directly compare the binding constants of the various 
receptors due to varying experimental techniques and conditions in the different references. 
Hence, it seems not constructive to choose the methyllysine host with the lowest dissociation 
constant and nominate a ‘winner’. Different applications will require different receptor 
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properties. Depending on the envisaged use overall charge or pH dependency[105] may be more 
important than selectivity. In some cases competing guests such as Nα-methylamino acids
[67] 
or arginine[106] need to be considered; some receptors may not be stable under the assessed 
conditions, e.g. due to S-S bonds.[107] In some cases the low solubility in water may restricted 
the applications of the ‘synthetic antibodies’. Another possible challenge is the provision of the 
artificial methyllysine host: tetrasulfonatocalix[4]arene (1) and cucurbit[7]uril (39) are both 
commercially available, many others require elaborate synthetic procedures making it more 
difficult for users beyond chemistry to work with them.  
 
Interestingly, only a rather low number of X-ray structures of methyllysine complexes have 
been described. Thereby, the binding preferences of the synthetic receptor in solution is not 
always directly comparable with the situation in solid state – as shown for the rather 
promiscuous binding of some title compounds. However, X-ray structures of methyllysine 
inclusion compounds and complexes give valuable information on non-covalent interactions 
between host and guest and can help to further improve the selectivity and specificity (generic 
vs. specific receptors).  
 
On the long run, research on hosts for methyllysines will also benefit the development of 
‘artificial antibodies’ for similar post-translational modifications such as methylarginine,[108] 
methylhistidine,[109] and methyladenin.[110] The general concepts found for methyllysine 
binding will further stimulate the recognition of related guest species such as methylamines 
like ecstasy,[111] amphetamines[112] or other illegal substances.[113] Already, synthetic 
methyllysine receptors have prompted the development of macrocycles for the detoxification 
of organophosphonates, which can be – and are – misused as chemical warfare agents. By way 
of example, Kubik and co-workers reported on a series of trisulfonatocalixarenes for the 
catalytic hydrolysis of V-type nerve agents and soman demonstrating once again the variability 
of calixarene hosts (Scheme 20).[114]  
 
A) 
 
B) 
 
 
Scheme 20. Structures of soman and VX (A) as well as catalytic-active 
trisulfonatocalixarenes 41 and 42 for their accelerated hydrolysis (B). 
 
 
9. Future research directions and challenges 
 
The most successful candidates for the recognition of methylated lysines are macrocycles. They 
have clearly defined cavities featuring high grades of preorganization paired with controlled 
flexibility. Macrocycles are deployable as platforms for multivalent systems and functional 
groups can be introduced at specific sites allowing fine-tuned hosts. The field of methyllysine 
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recognition is still in its infancies and the author of this review can only speculate about future 
developments. It can be assumed that prospective receptors will be designed either to be 
specific or generic in their recognition behavior – in both cases with high Kme0/Kmex 
selectivity. As proposed by the author and co-workers macrocycles with intrinsic fluorescence 
could be one way forward.[59] Furthermore, bioinformatics combined with molecular modelling 
and crystallographic approaches will help to design new generations of ‘artificial antibodies’ 
for the recognition of the methyllysine motif. A challenge for the future is clearly the better 
comparability between the different synthetic hosts. The reviewed literature uses six different 
analytical techniques to determine the dissociations constant of respective complexes, which 
makes authentic structure-activity relationships rather difficult. It would also be helpful to 
screen not only lysine and trimethyllysine, but also mono- and dimethyllysines.  
As shown in Scheme 2 synthetic receptors for trimethyllysines offer a broad range of 
applications. Significant progress has been made for the analysis and purification of 
methyllysines. In several cases the target compounds have been employed in assays using 
demethylases and/or methyltransferases. Moreover, the biological activity of some 
methyllysine receptors is a promising start for new therapeutic agents. In no way synthetic 
receptors will be able to fully replace antibodies, though the reviewed literature delivers 
promising points of contacts for amendatory applications.  
The use of synthetic methyllysine receptor as therapeutic agents is only possible with an 
acceptable toxicity. Single injected doses of tetrasulfonatocalixarene 1 (equivalent to 2-5 g in 
humans) showed no acute toxicity[115] and no toxicity towards various tumor cell lines has been 
observed.[116] It develops no haemolytic toxicity observed for concentrations up to 5 mM[117] 
and is not activating neutrophils, hence, does not induce an immune response[118]. Also 
cucurbiturils have demonstrated a rather low toxicity.[119] Despite they are able to cross the cell 
membrane of mouse embryo cells,[120] cucurbiturils lack of cytotoxicity in mammalian cells 
(up to 1 mM).[121] Intravenously administered cucuribt[7]uril (39) has demonstrated no toxicity 
at doses up to 200 mg/kg,[122] though has a measureable cardiotoxicity at concentrations > 500 
μM.[123] Other synthetic receptors for methyllysine may have much higher toxicity levels, 
whose determination should be a point of contact for further studies.  
 
Most of the synthetic receptors for methyllysines discussed here also recognize a broad range 
of other alkylammonium ions. In some cases the latter are complexed with even higher 
affinities than methyllysines. As most applications use the recognition of methylated lysines in 
biological media naturally occurring alkylammonium ions may disturb the desired recognition 
event. An example are cucurbiturils, that – when transferred into the cell – would not only 
recognize methyllysines, but may also interact with spermine and spermidine with the resulting 
complexes affecting DNA-modifying enzymes.[124] More studies are necessary to rule out 
cross-interactions, especially as hosts 1 and 14-16 have been described to disrupt the interaction 
of histone peptides with their natural protein binder, hence, already demonstrated their 
influence on DNA activity.  
 
Another broad topic for future research are off-target effects of synthetic receptors for 
methylated lysines. A possible example is tetrasulfonatocalixarene 1 and its ability to hydrolyze 
ATP (Scheme 21).[125] After application of 1 on cells or on organisms – aiming for the 
discrimination of methyllysines – the artificially decreased ATP level could lead to artefacts as 
(ATP)-dependent chromatin remodeling enzymes[126] may be influenced. Would other 
sulfonatocalixarenes be active as well? Other untried interactions are conceivable as 1 is also 
a high affinity blocker of chloride channels[127] and volume-regulated anion channels.[128] 
Furthermore, it is known for its antithrombotic and anticoagulant properties.[129] By way of 
interest, both calixarene 1 and cucurbituril 39 inhibit amyloid fibrillation by multipoint 
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hydrophobic interactions,[130] which may lead to competing host/guest interactions in 
respective systems.  
 
 
 
Scheme 21. Proposed complex of 1 with ATP 
during the catalytic hydrolysis of the guest.[125]  
 
The blood-brain barrier prevents the uptake of large hydrophilic and highly anionic artificial 
hosts as shown for tetrasulfonatocalixarene 1.[115] Nevertheless, in the long term the use of 
synthetic receptors for methyllysines in the brain may be feasible. Several methyllysine 
receptors (e.g. 23, 39, etc.) have also a high affinities to acetylcholine and the complexation of 
the neurotransmitter could lead to artefacts when screening for methyllysines. Possible are also 
off-target effects: receptor 43 (Scheme 22) – closely related to tetracyano receptor 23 – was 
found to inhibit the hydrolysis of acetylcholine,[131] hence, may influence synapse activities. 
Future research could help to establish if guest hydrolysis is a general characteristic of synthetic 
trimethylammonium receptors.  
 
 
 
Scheme 22. Resorcinarene 43 is an inhibitor of 
acetylcholine hydrolysis.  
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